Role of respiratory syncytial virus in acute otitis media

Implications for vaccine development

Janak Patel, Dang T. Nguyen, Krystal Revai, Tasnee Chonmaitree

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

We summarize herein the results of various virologic studies of acute otitis media (AOM) conducted at our site over a 10-year period. Among 566 children with AOM, respiratory syncytial virus (RSV) was the most common virus identified in either middle ear fluid or nasal wash; it was found in 16% of all children and 38% of virus-positive children. Seventy-one percent of the children with RSV were 1 year of age or older, which was significantly older than all other viruses combined (P = 0.045). RSV infection was associated with the common bacterial pathogens causing AOM. Past efforts to develop vaccines for RSV have emphasized prevention of lower respiratory tract infection in infants, which is a more serious problem but less common than AOM. Our results suggest that RSV vaccines that work only against infection in older children may have value in preventing AOM, the most common pediatric disease.

Original languageEnglish (US)
Pages (from-to)1683-1689
Number of pages7
JournalVaccine
Volume25
Issue number9
DOIs
StatePublished - Feb 19 2007

Fingerprint

otitis media
Respiratory Syncytial Viruses
vaccine development
Otitis Media
Vaccines
Respiratory Syncytial Virus Vaccines
viruses
Viruses
Respiratory Syncytial Virus Infections
Middle Ear
Nose
Respiratory Tract Infections
vaccines
Pediatrics
infection
respiratory tract diseases
ears
Infection
pathogens

Keywords

  • Otitis media
  • Respiratory syncytial virus
  • Vaccine

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Virology
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)

Cite this

Role of respiratory syncytial virus in acute otitis media : Implications for vaccine development. / Patel, Janak; Nguyen, Dang T.; Revai, Krystal; Chonmaitree, Tasnee.

In: Vaccine, Vol. 25, No. 9, 19.02.2007, p. 1683-1689.

Research output: Contribution to journalArticle

Patel, Janak ; Nguyen, Dang T. ; Revai, Krystal ; Chonmaitree, Tasnee. / Role of respiratory syncytial virus in acute otitis media : Implications for vaccine development. In: Vaccine. 2007 ; Vol. 25, No. 9. pp. 1683-1689.
@article{9914775fa08e4827b3511c825f9f04e9,
title = "Role of respiratory syncytial virus in acute otitis media: Implications for vaccine development",
abstract = "We summarize herein the results of various virologic studies of acute otitis media (AOM) conducted at our site over a 10-year period. Among 566 children with AOM, respiratory syncytial virus (RSV) was the most common virus identified in either middle ear fluid or nasal wash; it was found in 16{\%} of all children and 38{\%} of virus-positive children. Seventy-one percent of the children with RSV were 1 year of age or older, which was significantly older than all other viruses combined (P = 0.045). RSV infection was associated with the common bacterial pathogens causing AOM. Past efforts to develop vaccines for RSV have emphasized prevention of lower respiratory tract infection in infants, which is a more serious problem but less common than AOM. Our results suggest that RSV vaccines that work only against infection in older children may have value in preventing AOM, the most common pediatric disease.",
keywords = "Otitis media, Respiratory syncytial virus, Vaccine",
author = "Janak Patel and Nguyen, {Dang T.} and Krystal Revai and Tasnee Chonmaitree",
year = "2007",
month = "2",
day = "19",
doi = "10.1016/j.vaccine.2006.10.045",
language = "English (US)",
volume = "25",
pages = "1683--1689",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "9",

}

TY - JOUR

T1 - Role of respiratory syncytial virus in acute otitis media

T2 - Implications for vaccine development

AU - Patel, Janak

AU - Nguyen, Dang T.

AU - Revai, Krystal

AU - Chonmaitree, Tasnee

PY - 2007/2/19

Y1 - 2007/2/19

N2 - We summarize herein the results of various virologic studies of acute otitis media (AOM) conducted at our site over a 10-year period. Among 566 children with AOM, respiratory syncytial virus (RSV) was the most common virus identified in either middle ear fluid or nasal wash; it was found in 16% of all children and 38% of virus-positive children. Seventy-one percent of the children with RSV were 1 year of age or older, which was significantly older than all other viruses combined (P = 0.045). RSV infection was associated with the common bacterial pathogens causing AOM. Past efforts to develop vaccines for RSV have emphasized prevention of lower respiratory tract infection in infants, which is a more serious problem but less common than AOM. Our results suggest that RSV vaccines that work only against infection in older children may have value in preventing AOM, the most common pediatric disease.

AB - We summarize herein the results of various virologic studies of acute otitis media (AOM) conducted at our site over a 10-year period. Among 566 children with AOM, respiratory syncytial virus (RSV) was the most common virus identified in either middle ear fluid or nasal wash; it was found in 16% of all children and 38% of virus-positive children. Seventy-one percent of the children with RSV were 1 year of age or older, which was significantly older than all other viruses combined (P = 0.045). RSV infection was associated with the common bacterial pathogens causing AOM. Past efforts to develop vaccines for RSV have emphasized prevention of lower respiratory tract infection in infants, which is a more serious problem but less common than AOM. Our results suggest that RSV vaccines that work only against infection in older children may have value in preventing AOM, the most common pediatric disease.

KW - Otitis media

KW - Respiratory syncytial virus

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=33846247462&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846247462&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2006.10.045

DO - 10.1016/j.vaccine.2006.10.045

M3 - Article

VL - 25

SP - 1683

EP - 1689

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 9

ER -